Leading European scientists convene in Lisbon today to undertake the risk assessment of a new psychoactive substance currently raising health concerns in Europe. The substance in question, the stimulant drug 4,4?-DMAR, is the fifth new drug to be risk assessed this year. To date, the substance has been linked to 31 deaths in the EU.


Pour en lire plus...